OrphanDrug
OrphanDrug
Pharma Knowledge Base

dysequilibrium syndrome

MeSH: C535731ORPHA: 1766

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Dysequilibrium syndrome (DES) is a non-progressive cerebellar disorder characterized by ataxia associated with an intellectual disability, delayed ambulation and cerebellar hypoplasia

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with dysequilibrium syndrome, sourced from HPO and Orphanet clinical annotations.

Abnormality of the eyeStrabismusAbnormality of visionCataractIntellectual disabilitySeizureAtaxiaHypotoniaGait disturbanceHyperreflexiaSkeletal muscle atrophyShort statureCerebral palsyAbnormality of movement

Classification & Codes

MeSH Code

C535731

Orphanet Code

ORPHA:1766
dysequilibrium syndrome
MeSHC535731
OrphanetORPHA:1766
Treatments0 drug(s)
Symptoms on record14 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO